Pharmacotherapy in paediatric obsessive-compulsive disorder: A naturalistic, retrospective study

CNS Drugs

Volumn 23, Issue 3, 2009, Pages 241-252

  Masi, Gabriele ^a   Millepiedi, Stefania ^a   Perugi, Giulio ^b,c   Pfanner, Chiara ^a   Berloffa, Stefano ^a   Pari, Cinzia ^a   Mucci, Maria ^a  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CLOMIPRAMINE; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; LITHIUM; METHYLPHENIDATE; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONDUCT DISORDER; CONSULTATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISRUPTIVE BEHAVIOR; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSESSIVE COMPULSIVE DISORDER; PANIC; PATIENT CARE; PEDIATRICS; POLYPHARMACY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOTHERAPY; RETROSPECTIVE STUDY; TIC; TREATMENT RESPONSE;

ADOLESCENT; AGE FACTORS; AGE OF ONSET; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TREATMENT FAILURE;

EID: 63149178640     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200923030-00005     Document Type: Article

References (31)

1. Barrett P, Healy-Farrell L, March JS. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 2004; 43: 46-62
2. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination in children and adolescents with obsessive-compulsive disorder: Pediatric OCD Treatment Study (POTS) randomized controlled trial. J Am Med Assn 2004; 292: 1969-76
3. De Veaugh-Geiss J, Moroz G, Biederman J, et al. Clomipramine hydrocloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial. J Am Acad Child Adolesc Psychiatry 1992; 31: 45-9
4. Flament MF, Rapoport JL, Berg CJ, et al. Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study. Arch Gen Psychiatry 1985; 42: 977-83
5. March JS, Biederman J, Wolchow R, et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. J Am Med Assn 1998; 280: 1752-6
6. Riddle MA, Reeve EA, Yaryura-Tobias JA, et al. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled multicenter trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 222-9
7. Geller DA, Hoog SL, Heiligenstein JH, et al. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 773-9
8. Geller DA, Wagner KD, Emslie G, et al. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2004; 43: 1387-96
9. Geller DA, Biederman J, Stewart SE, et al. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatry 2003; 160: 1919-28
10. McDougle CJ. Update on pharmacologic management of OCD: agents and augmentation. J Clin Psychiatry 1997; 12 (58 Suppl.): 7-11
11. Grados M, Riddle MA. Do all obsessive-compulsive disorder subtypes respond to medication? Int Rev Psychiatry 2008; 20: 189-93
12. Masi G, Millepiedi S, Mucci M, et al. A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adol Psychiatry 2005; 44: 673-81
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
14. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-8
15. Guy W. ECDEU assessment manual for psychopharmacology. Rockville (MD): National Institute of Mental Health, 1976
16. Shaffer D, Gould M, Brasic J, et al. Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 1983; 40: 1228-31
17. Goodman WK, Price LH, Rasmussen LH, et al. The Yale-Brown Obsessive Compulsive Scale: I. Development, use and reliability. Arch Gen Psychiatry 1989; 46: 1006-11
18. Masi G, Millepiedi S, Mucci M, et al. Comorbidity of obsessive-compulsive disorder and ADHD in referred children and adolescents. Compr Psychiatry 2006; 47: 42-7
19. Masi G, Perugi G, Millepiedi S, et al. Bipolar comorbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications. J Child Adolesc Psychopharmacol 2007; 17: 475-86
20. Leckman JF, Grice DE, Boardman J, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 1997; 154: 911-7
21. Delorme R, Bille A, Betancur C, et al. Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: a prospective follow-up study. BMC Psychiatry 2006; 6: 1
22. Stewart SE, Rosario MC, Brown TA, et al. Principal component analysis of obsessive-compulsive disorder symptoms in children and adolescents. Biol Psychiatry 2007; 61: 285-91
23. Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997; 36: 844-52
24. Storch EA, Murphy TK, Geffken GR, et al. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale. Psychiatry Res 2004; 129: 91-8
25. Masi G, Perugi G, Toni C, et al. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord 2004; 78: 175-83
26. March JS, Franklin ME, Leonard H, et al. Tics moderate the treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007; 61: 344-7
27. Geller DA, Biederman J, Stewart SE, et al. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol 2003; 1 (13 Suppl.): S19-29
28. Black DW, Monahan P, Gable J, et al. Hoarding and treatment response in 38 non-depressed subjects with obsessive-compulsive-disorder. J Clin Psychiatry 1998; 59: 420-5
29. Mataix-Cols D, Rauch SL, Manzo PA, et al. Use of factoranalyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 1999; 156: 1409-16
30. Wheaton M, Timpano KR, LaSalle-Ricci VH, et al. Characterizing the hoarding phenotype in individuals with OCD: associations with comorbidity, severity and gender. J Anxiety Disord 2008; 22 (2): 243-52
31. Winsberg ME, Cassic KS, Koran IM. Hoarding in obsessive-compulsive disorder: a report of 20 cases. J Clin Psychiatry 1999; 60: 591-7